← Back to patent-cliff list
Tizanidine Hydrochloride
Tier C — Watch / tradeTizanidine Hydrochloride
-
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ADRA2
Brand：Zanaflex, Enchinin, Sirdalud, Ternelin
Indications (approved)：Multiple sclerosis, Muscle spasm
Regional status
US
Approved
1996-11-27
EU
-
China
Approved
2004-01-21
Japan
Approved
1996-03-05
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tizanidine Hydrochloride?
Approved indications include: Multiple sclerosis, Muscle spasm.
When does the Tizanidine Hydrochloride patent expire?
No public expiry year is available for Tizanidine Hydrochloride yet; this page updates once verified.
How do I get a quote for Tizanidine Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04